Tag: PMV Pharmaceuticals
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586...
PC14586 selectively stabilizes the p53 Y220C mutant and restores p53 activityRobust in vivo tumor regression observed with once daily oral dosingPharmacodynamic biomarkers of...